DNIB Unwind Inc

bind therapeutics is a biotechnology company incorporated in 2006; pfizer acquired substantially all of its assets in 2016. bind’s product candidates were based on proprietary polymeric nanoparticles called accurins®, which are engineered to target specific cells and tissues in the body at sites of disease. accurins®, which continue to be developed with pfizer, have the potential to achieve therapeutic outcomes not currently possible with conventional treatment modalities.

Provatelo velocemente con tomba.io.

Informazioni su DNIB Unwind Inc

Sito web

bindtherapeutics.com

Fondato

2006

Numero di dipendenti

1-10

Industria

biotechnology

Paese

US

Stato

Massachusetts

Città

Cambridge

Indirizzo

-71.10

Numero di telefono

(617) 491-3400

Email pattern

{f}{last}

Email Accept all Stato

False

Email Blocked Stato

False

Whois Data di creazione

February 27th 2013, 05:54:42 pm

RWhois

www.markmonitor.co...

Whois Name

MarkMonitor Inc.

Total Emails

36

Total Personal Emails

32

Total Generic Emails

4

Last updated

April 4th 2023, 09:05:41 pm

Trova l'e-mail di chiunque dietro qualsiasi sito web

Conti sociali di DNIB Unwind Inc

Tutti gli indirizzi email per bindtherapeutics.com

nicholas boylan

n***@bindtherapeutics.com
Non siamo riusciti a trovare questo indirizzo email pubblicamente disponibile sul Web.

scientist

0 Sources

tatiana sitnova

t***@bindtherapeutics.com
Non siamo riusciti a trovare questo indirizzo email pubblicamente disponibile sul Web.

Legal Director

0 Sources

dan koerwer

d***@bindtherapeutics.com
Non siamo riusciti a trovare questo indirizzo email pubblicamente disponibile sul Web.

chief business officer

0 Sources

scott minick

s***@bindtherapeutics.com
Non siamo riusciti a trovare questo indirizzo email pubblicamente disponibile sul Web.

ceo

0 Sources

christina seretta

c***@bindtherapeutics.com
Non siamo riusciti a trovare questo indirizzo email pubblicamente disponibile sul Web.

hr associate

0 Sources

brenda duane

b***@bindtherapeutics.com
Non siamo riusciti a trovare questo indirizzo email pubblicamente disponibile sul Web.

director hr

0 Sources

laurie travers

l***@bindtherapeutics.com
Non siamo riusciti a trovare questo indirizzo email pubblicamente disponibile sul Web.

staffing consultant

0 Sources

scott minick

s***@bindtherapeutics.com
Non siamo riusciti a trovare questo indirizzo email pubblicamente disponibile sul Web.

0 Sources

jean kung

j***@bindtherapeutics.com
Non siamo riusciti a trovare questo indirizzo email pubblicamente disponibile sul Web.

clinical project manager data manager

0 Sources

peter endicott

p***@bindtherapeutics.com
Non siamo riusciti a trovare questo indirizzo email pubblicamente disponibile sul Web.

head facilities

0 Sources

26 altro per la tua ricerca bindtherapeutics.com

Crea un account per scoprire gli indirizzi e-mail, ottenere risultati completi, filtri di ricerca, download CSV e altro ancora.

Formato e-mail

EmailPattern #

johndoe@bindtherapeutics.com

{first}{last}

No

john.doe@bindtherapeutics.com

{first}.{last}

No

john-doe@bindtherapeutics.com

{first}-{last}

No

doejohn@bindtherapeutics.com

{last}{first}

No

doe.john@bindtherapeutics.com

{last}.{first}

No

doe-john@bindtherapeutics.com

{last}-{first}

No

jdoe@bindtherapeutics.com

{f}{last}

Available

j.doe@bindtherapeutics.com

{f}.{last}

No

j-doe@bindtherapeutics.com

{f}-{last}

No

johnd@bindtherapeutics.com

{first}{l}

No

john.d@bindtherapeutics.com

{first}.{l}

No

john-d@bindtherapeutics.com

{first}-{l}

No

djohn@bindtherapeutics.com

{l}{first}

No

d.john@bindtherapeutics.com

{l}.{first}

No

d-john@bindtherapeutics.com

{l}-{first}

No

doej@bindtherapeutics.com

{last}{f}

No

doe.j@bindtherapeutics.com

{last}.{f}

No

doe-j@bindtherapeutics.com

{last}-{f}

No

john@bindtherapeutics.com

{first}

No

doe@bindtherapeutics.com

{last}

No

jd@bindtherapeutics.com

{f}{l}

No

j.d@bindtherapeutics.com

{f}.{l}

No

j-d@bindtherapeutics.com

{f}-{l}

No

dj@bindtherapeutics.com

{l}{f}

No

d.j@bindtherapeutics.com

{l}.{f}

No

d-j@bindtherapeutics.com

{l}-{f}

No

Domande frequenti su DNIB Unwind Inc

Where is DNIB Unwind Inc's physical location?

DNIB Unwind Inc is headquartered in US.

Can you detail the whois information for DNIB Unwind Inc's domain?

DNIB Unwind Inc's domain whois information was last updated on 2013-02-27T18:54:42+01:00, The registrant name associated with the domain is MarkMonitor Inc..

What are the key industries and company size for DNIB Unwind Inc?

DNIB Unwind Inc operates within the biotechnology industry and reports a company size of 1-10 employees.

Can you provide DNIB Unwind Inc's contact information?

Certainly, DNIB Unwind Inc can be reached at the phone number (617) 491-3400.

What is the total number of emails cataloged by DNIB Unwind Inc?

As of the latest update, DNIB Unwind Inc has cataloged a total of 36 emails.

Does DNIB Unwind Inc have any restrictions on the types of emails it accepts?

DNIB Unwind Inc does not indiscriminately accept all types of emails. The platform has specific criteria and verification processes to ensure the validity and relevance of the email addresses it lists, reflecting its policy on accepting specific types of emails.

Is there any block on DNIB Unwind Inc's email finding capabilities?

No, there is no block on DNIB Unwind Inc's email finding capabilities, confirming that the service operates freely without no restrictions.

How can one connect with DNIB Unwind Inc on social media?

DNIB Unwind Inc maintains an active presence on major social media platforms, including Twitter (BINDTx), Facebook (BINDTHERA), and LinkedIn (3050288).

What email pattern does DNIB Unwind Inc utilize for creating email addresses?

DNIB Unwind Inc employs the email naming pattern '{f}{last}''

What is the geographical location of DNIB Unwind Inc's headquarters?

DNIB Unwind Inc is headquartered in Cambridge, Massachusetts, US. The precise location is marked by the street address -71.10.

Sfoglia le aziende

Il nostro indice aziendale contiene centinaia di migliaia di aziende.